Copyright thehindubusinessline
Healthcare major Apollo Hospitals Enterprise Limited (AHEL) on Thursday reported a 26 per cent year-on-year (y-o-y) growth in consolidated net profit, to ₹477 crore, for the quarter that ended September 2025 (Q2 FY26) with all segments – hospital services, diagnostics, and digital healthcare – clocking robust growth. Group revenue rose 13 per cent y-o-y, to end at ₹6,304 crore. For the half year that ended September (H1 FY26), consolidated revenues grew 14 per cent y-o-y, to ₹12,146 crore and consolidated PAT (profit after tax) grew 33 per cent y-o-y, to ₹910 crore. “On the operational side, our hospitals have continued to attract the most complex cases from across India and beyond, achieving a 69 per cent occupancy and a 9 per cent increase in revenue,” Dr Prathap C Reddy, Chairman, AHEL, said in a statement. Dr Madhu Sasidhar, President & CEO, Hospitals Division, Apollo Hospitals, told businessline that revenue growth has been of quality and outlook for FY26 is positive driven by the investments made in our consultants and CONGO [Cancer, Ortho, Neuro, Gastro, Oncology] specialties. Healthcare services On the muted growth in healthcare services (HCS) segment revenue of 9 per cent y-o-y, Sasidhar said that Q2 FY25 had a higher incidence of seasonal medical admissions, leading to a high base, whereas admissions were low in Q2 FY26. “But this was partly offset by a 14 per cent rise in revenue from CONGO segment,” he added. During the quarter, the reduction in Bangladesh patients has had an impact of 1 per cent on HCS revenue. “We are at 65-70 per cent of the peak volumes of patients from Bangladesh, and it is coming back. We are also seeing an increase in [patients from] other international markets such as Malaysia and CIS nations,” said Sasidhar. Krishnan Akhileswaran, CFO, Apollo Hospitals, said that Apollo Health Co, the segment that operates the Apollo 24/7 digital platform and pharmacy business, is on track to break even within the next two quarters. On expansion, he said that a series of hospitals will get commissioned over the next 15 months comprising 1700 beds. During the quarter, the Competition Commission of India approved the restructuring plan involving Apollo HealthCo, Keimed, and Apollo Healthtech. “We are awaiting stock exchange approvals and the new entity is likely to list by Q4 FY27,” said Akhileswaran. Published on November 6, 2025
